Xiaodong Jiao

Publications

• Expert Consensus on the Diagnosis and Treatment of RET Gene Fusion Non-small Cell Lung Cancer in China
  Thoracic Cancer. Sep, 2023  |   Pubmed ID: 37718634
• Pan-cancer Efficacy and Safety of Anlotinib Plus PD-1 Inhibitor in Refractory Solid Tumor: A Single-arm, Open-label, Phase II Trial
  International Journal of Cancer. Aug, 2023  |   Pubmed ID: 37155342
• Targeted Therapy for Intractable Cancer on the Basis of Molecular Profiles: An Open-label, Phase II Basket Trial (Long March Pathway)
  Frontiers in Oncology. 2023  |   Pubmed ID: 36910668
• Prognostic Value of Tumor Mutation Burden in Patients with Advanced Gastric Cancer Receiving First-line Chemotherapy
  Frontiers in Oncology. 2022  |   Pubmed ID: 36686739
• Double Spiral Chip-embedded Micro-trapezoid Filters (SMT Filters) for the Sensitive Isolation of CTCs of Prostate Cancer by Spectral Detection
  Nanoscale Advances. Dec, 2022  |   Pubmed ID: 36540122
• Low-dose Anti-VEGFR2 Therapy Promotes Anti-tumor Immunity in Lung Adenocarcinoma by Down-regulating the Expression of Layilin on Tumor-infiltrating CD8T Cells
  Cellular Oncology (Dordrecht). Dec, 2022  |   Pubmed ID: 36260222
• Effect of Smoking Habits on the Efficacy of EGFR-TKI Plus Anti-angiogenic Agent in Advanced EGFR-mutant NSCLC
  Lung Cancer (Amsterdam, Netherlands). Aug, 2022  |   Pubmed ID: 35728482
• Cetuximab and Vemurafenib Plus FOLFIRI (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated Advanced Colorectal Cancer (IMPROVEMENT): An Open-label, Single-arm, Phase II Trial
  European Journal of Cancer (Oxford, England : 1990). Mar, 2022  |   Pubmed ID: 35074651
• Blood Small Extracellular Vesicles Derived MiRNAs to Differentiate Pancreatic Ductal Adenocarcinoma from Chronic Pancreatitis
  Clinical and Translational Medicine. Sep, 2021  |   Pubmed ID: 34586739
• Serum Tumor Markers for the Prediction of Concordance Between Genomic Profiles from Liquid and Tissue Biopsy in Patients with Advanced Lung Adenocarcinoma
  Translational Lung Cancer Research. Jul, 2021  |   Pubmed ID: 34430361
• Effects of Concomitant Proton Pump Inhibitor Use on Immune Checkpoint Inhibitor Efficacy Among Patients with Advanced Cancer
  Oncoimmunology. 2021  |   Pubmed ID: 34350061
• Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report
  JCO Precision Oncology. 2021  |   Pubmed ID: 34036227
• HER2 Splice Site Mutation C.1899-1G>A As the Potential Acquired Resistance to Trastuzumab in a Patient with HER2-Positive Gastric Adenocarcinoma
  The Oncologist. Sep, 2021  |   Pubmed ID: 33896090
• Primary Squamous Cell Carcinoma of Pancreas: a Population-based Study
  Gland Surgery. Mar, 2021  |   Pubmed ID: 33842247
• Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis
  The Oncologist. Apr, 2021  |   Pubmed ID: 32997436
• Comparing Immunotherapies in Combination With Chemotherapy for Previously Untreated Advanced Nonsquamous NSCLC
  Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Dec, 2020  |   Pubmed ID: 33246598
• Tumor Mutation Burden in Chinese Cancer Patients and the Underlying Driving Pathways of High Tumor Mutation Burden Across Different Cancer Types
  Annals of Translational Medicine. Jul, 2020  |   Pubmed ID: 32793704
• Response to Pyrotinib in a Chinese Patient with Bone-Metastatic Scrotal Paget's Disease Harboring Triple Uncommon HER2 Mutation: A Case Report
  OncoTargets and Therapy. 2020  |   Pubmed ID: 32753879
• The Effect of Liver Metastasis on Efficacy of Immunotherapy Plus Chemotherapy in Advanced Lung Cancer
  Critical Reviews in Oncology/hematology. Mar, 2020  |   Pubmed ID: 32065969
• Palbociclib for the Treatment of Metastatic Nasopharyngeal Carcinoma With CDK4 Amplification: A Case Report
  JCO Precision Oncology. Dec, 2019  |   Pubmed ID: 35100720
• The Prognostic Value of Tumor Mutation Burden in -mutant Advanced Lung Adenocarcinoma, an Analysis Based on CBioPortal Data Base
  Journal of Thoracic Disease. Nov, 2019  |   Pubmed ID: 31903239
• MTSS1 Inhibits Metastatic Potential and Induces G2/M Phase Cell Cycle Arrest in Gastric Cancer
  OncoTargets and Therapy. 2019  |   Pubmed ID: 31303767
• Identification of a Novel EML4-ALK, BCL11A-ALK Double-Fusion Variant in Lung Adenocarcinoma Using Next-Generation Sequencing and Response to Crizotinib
  Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Jun, 2019  |   Pubmed ID: 31122560
• The RNA-Binding Protein HuR Confers Oxaliplatin Resistance of Colorectal Cancer By Upregulating CDC6
  Molecular Cancer Therapeutics. Jul, 2019  |   Pubmed ID: 31064870
• Basket Trials for Intractable Cancer
  Frontiers in Oncology. 2019  |   Pubmed ID: 31032221
• Clinical, Pathological and Treatment Factors Associated with the Survival of Patients with Primary Pulmonary Salivary Gland-type Tumors
  Lung Cancer (Amsterdam, Netherlands). Dec, 2018  |   Pubmed ID: 30527184
• The Effectiveness of Afatinib and Osimertinib in a Chinese Patient with Advanced Lung Adenocarcinoma Harboring a Rare Triple EGFR Mutation (R670W/H835L/L833V): a Case Report and Literature Review
  OncoTargets and Therapy. 2018  |   Pubmed ID: 30127622
• The Prognostic Value of TP53 and Its Correlation with EGFR Mutation in Advanced Non-small Cell Lung Cancer, an Analysis Based on CBioPortal Data Base
  Lung Cancer (Amsterdam, Netherlands). Sep, 2018  |   Pubmed ID: 30089598
• Tumor Mutation Burden to Tumor Burden Ratio and Prediction of Clinical Benefit of Anti-PD-1/PD-L1 Immunotherapy
  Medical Hypotheses. Jul, 2018  |   Pubmed ID: 29857892
• ADAM-17 is a Poor Prognostic Indicator for Patients with Hilar Cholangiocarcinoma and is Regulated by FoxM1
  BMC Cancer. May, 2018  |   Pubmed ID: 29776401
• Adenosquamous Carcinoma of the Bile Duct: a Population-based Study
  Cancer Management and Research. 2018  |   Pubmed ID: 29563834
• Rapid Symptomatic Relief of HER2-positive Gastric Cancer Leptomeningeal Carcinomatosis with Lapatinib, Trastuzumab and Capecitabine: a Case Report
  BMC Cancer. Feb, 2018  |   Pubmed ID: 29463236
• Primary Pulmonary Leiomyosarcoma: A Population-based Study
  Lung Cancer (Amsterdam, Netherlands). Feb, 2018  |   Pubmed ID: 29413053
• Increased SNAT1 is a Marker of Human Osteosarcoma and Potential Therapeutic Target
  Oncotarget. Oct, 2017  |   Pubmed ID: 29108276
• [Advances in Patient Derived Tumor Xenograft (PDTX) Model from Lung Cancer]
  Zhongguo Fei Ai Za Zhi = Chinese Journal of Lung Cancer. Oct, 2017  |   Pubmed ID: 29061220
• Paralytic Ileus Due to a Novel Anticancer Drug, Nab-paclitaxel: A Case Report
  Molecular and Clinical Oncology. May, 2016  |   Pubmed ID: 27123288
• Metformin Potentiates Rapamycin and Cisplatin in Gastric Cancer in Mice
  Oncotarget. May, 2015  |   Pubmed ID: 25909163
• [Clinical Observation of Prophylactic Lactulose for Prevention of Oral Morphine-induced Constipation]
  Zhonghua Yi Xue Za Zhi. Nov, 2012  |   Pubmed ID: 23328286
• Pemetrexed Versus Docetaxel in Second Line Non-small-cell Lung Cancer: Results and Subsets Analyses of a Multi-center, Randomized, Exploratory Trial in Chinese Patients
  Pulmonary Pharmacology & Therapeutics. Oct, 2012  |   Pubmed ID: 22766314
• Effect of Sunitinib Combined with Ionizing Radiation on Endothelial Cells
  Journal of Radiation Research. 2011  |   Pubmed ID: 21187670